15Dec
Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment
The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in this push for advancement, including sectors attracting the most dollars in today’s challenging business landscape, key issues that early stage...
By:
McDermott Will & Emery
Related
Oh, wait. According to a recent study, women pay 20 percent more than men in bank fees and penaltie...
Read More >
On December 20, 2019, the IRS issued proposed regulations under Section 162(m) of the Internal Reven...
Read More >
As we previously reported, Nevada has enacted a personal leave law, which, effective January 1, 2020...
Read More >
The Situation: The Australian Government has temporarily reduced the monetary thresholds under the F...
Read More >
Financial institutions M&A sector trends: payments — H2 2019 and outlook for 2020. Megadeals, incl...
Read More >
In this episode of Phorensically Speaking, Jonathan Marks looks at corporate governance approaches t...
Read More >